HIV: treatments and prevention for longevity
This Thematic Series explores current methods to prevent the spread of HIV, alongside those currently in development. This can include the varying types of HIV vaccine in development (e.g., mRNA, T-Cell), our understanding of selective immunity in certain individuals, the efficacy of pre-exposure prophylaxis and more. While prevention is one part of reducing the spread of HIV, the treatments available to patients once diagnosed are equally as important. How clinicians and society approach HIV and its treatment is crucial for progress. The Series examines the importance of accessibility of treatment, mental health, and external support networks in the treatment of HIV.
Edited by
Olubunmi Akindele Ogunrin(University Hospitals of North Midlands NHS Trust, United Kingdom)
Olubunmi Ogunrin is a consultant neurologist with the University Hospitals of North Midlands in the United Kingdom. He obtained his PhD at University of Liverpool, United Kingdom. His research interests are in cognitive neurology of epilepsy and HIV/AIDS, and bioethics. Until recently, he was a professor of Internal Medicine/Neurology and Honorary Consultant Physician and Neurologist with the University of Benin and University Teaching Hospital, Nigeria, respectively.